HIGH-DOSE, PULSE INTRAVENOUS METHYLPREDNISOLONE ENHANCES FC-GAMMA-RECEPTOR MEDIATED MONONUCLEAR PHAGOCYTE FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：18
|
作者：
SALMON, JE
KAPUR, S
MERYHEW, NL
RUNQUIST, OA
KIMBERLY, RP
机构：
[1] UNIV MINNESOTA, DEPT MED, MINNEAPOLIS, MN 55455 USA
[2] HAMLINE UNIV, DEPT CHEM, ST PAUL, MN 55104 USA
来源：
ARTHRITIS AND RHEUMATISM | 1989年 / 32卷 / 06期
关键词：
D O I：
10.1002/anr.1780320609
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：717 / 725
页数：9
相关论文
共 50 条
  • [31] Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin
    Hundt, M
    Manger, K
    Dörner, T
    Grimbacher, B
    Kalden, P
    Rascu, A
    Weber, D
    Burmester, GR
    Peter, HH
    Kalden, JR
    Schmidt, RE
    RHEUMATOLOGY, 2000, 39 (11) : 1301 - 1302
  • [32] DEFECTIVE MONONUCLEAR PHAGOCYTE FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATIONSHIP OF FCRII (CD32) WITH INTERMEDIATE CYTOSKELETAL FILAMENTS
    VAZQUEZDOVAL, J
    SANCHEZIBARROLA, A
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 1993, 3 (02): : 86 - 91
  • [33] RETICULOENDOTHELIAL SYSTEM FC RECEPTOR FUNCTION AND PLASMAPHERESIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PRELIMINARY-REPORT
    HAMBURGER, MI
    GERARDI, EN
    FIELDS, TR
    BENNETT, RS
    ARTIFICIAL ORGANS, 1981, 5 (03) : 264 - 268
  • [34] MYELOFIBROSIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS - REVERSAL OF FIBROSIS WITH HIGH-DOSE CORTICOSTEROID-THERAPY
    INOUE, Y
    MATSUBARA, A
    OKUYA, S
    OKAFUJI, K
    KAKU, K
    KANEKO, T
    ACTA HAEMATOLOGICA, 1992, 88 (01) : 32 - 36
  • [35] PULMONARY-HYPERTENSION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - TREATMENT WITH HIGH-DOSE NIFEDIPINE THERAPY
    MACHET, L
    CALLENS, A
    MACHET, MC
    DESVEAUX, B
    VAILLANT, L
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1993, 18 (05) : 486 - 487
  • [36] CLINICOPATHOLOGICAL EVALUATION OF RENAL-FUNCTION AFTER INTRAVENOUS PULSE CYCLOPHOSPHAMIDE IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    GEORGAKOPOULOU, D
    SOTSIOU, F
    NIKOLOPOULOU, N
    MARAGOU, M
    CHRISTODOULIDOU, C
    STAVRIANAKI, D
    DANTIS, P
    BILLIS, A
    KIDNEY INTERNATIONAL, 1993, 44 (04) : 906 - 907
  • [37] DECREASED FC-RECEPTOR AVIDITY AND DEGRADATIVE FUNCTION OF MONOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    KATAYAMA, S
    CHIA, D
    KNUTSON, DW
    BARNETT, EV
    JOURNAL OF IMMUNOLOGY, 1983, 131 (01): : 217 - 222
  • [38] PROSPECTIVE EVALUATION OF INTRAVENOUS PULSE METHYLPREDNISOLONE FOLLOWED BY ALTERNATE-DAY CORTICOSTEROID-THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    BALLOU, SP
    KHAN, MA
    KUSHNER, I
    CLINICAL RESEARCH, 1984, 32 (04): : A819 - A819
  • [39] HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE PULSE THERAPY IN PATIENTS WITH RHEUMATOID DISEASE - PLASMA METHYLPREDNISOLONE LEVELS AND ADRENAL-FUNCTION
    BAYLIS, EM
    WILLIAMS, IA
    ENGLISH, J
    MARKS, V
    CHAKRABORTY, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (05) : 385 - 388
  • [40] RETICULOENDOTHELIAL SYSTEM FC RECEPTOR FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - EFFECT OF DECREASED SENSITIZATION ON CLEARANCE OF AUTOLOGOUS ERYTHROCYTES
    KABBASH, L
    ESDAILE, J
    SHENKER, S
    DECARY, F
    DANOFF, D
    FUKS, A
    SHUSTER, J
    JOURNAL OF RHEUMATOLOGY, 1987, 14 (03) : 487 - 489
12345